Clinical trial
Safety and Efficacy of Persistent Atrial Fibrillation Ablation With a Cryoballoon Technology
NCT06567652 is registered in ClinicalTrials.gov with Universitair Ziekenhuis Brussel as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Persistent Atrial Fibrillation Ablation With a Cryoballoon Technology
- Lead sponsor
- Universitair Ziekenhuis Brussel
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2021
- Completion date
- September 1, 2022
- Enrollment
- 80 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.